Related references
Note: Only part of the references are listed.Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring
Wei Zhao et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2013)
Pharmacokinetics of glycopeptide antibiotics in children
Hidekazu Ito et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2013)
Improved Vancomycin Dosing in Children Using Area Under the Curve Exposure
Jennifer Le et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Use of antibacterial agents in the neonate: 50 years of experience with vancomycin administration
Evelyne Jacqz-Aigrain et al.
SEMINARS IN FETAL & NEONATAL MEDICINE (2013)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children: Executive Summary
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations
Natasha E. Holmes et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Understanding pharmacokinetics/pharmacodynamics in managing neonatal sepsis
Irja Lutsar et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2010)
Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia
Alex Soriano et al.
CLINICAL INFECTIOUS DISEASES (2008)
Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections
Donald I. Hsu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Vancomycin - Pharmacokinetics and administration regimens in neonates
M de Hoog et al.
CLINICAL PHARMACOKINETICS (2004)
Evaluation and treatment of neonates with suspected late-onset sepsis:: A survey of neonatologists' practices -: art. no. e42
LG Rubin et al.
PEDIATRICS (2002)
Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy
MG Karlowicz et al.
PEDIATRICS (2000)
Vancomycin population pharmacokinetics in neonates
M de Hoog et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Share Paper
